t:connect Mobile Application, Mobile Bolus Enabled (iOS) 1007111Recalls & reported problems
Tandem Diabetes Care, Inc. · t:connect Mobile Application, Mobile Bolus Enabled, 2.x (iOS) · Class 2
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 90850018992452), received between Sep 9, 2022 and Mar 6, 2024 — classified as 2 injuries, 1 malfunction.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- Hypoglycemia2
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 6, 2024
TANDEM DIABETES RELEASED NEW T:CONNECT IOS SOFTWARE THAT INCREASED INSULIN PUMP POWER USE. TANDEM DIABETES HAS NOT NOTIFIED USERS OF DEFECTIVE SOFTWARE. THIS REPORT IS TO URGE FDA TO INVESTIGATE COMMUNICATION PRACTICES OF TANDEM DIABETES AND REQUIRE MUCH MORE TRANSPARENCY. REFERENCE REPORT: MW5152428.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18856049 ↗InjuryJun 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE CONTACT ACCIDENTALLY REQUESTED AND DELIVERED A 3 UNIT BOLUS VIA THE T:CONNECT MOBILE APPLICATION INSTEAD OF A BOLUS FOR 3 GRAMS OF CARBOHYDRATES. SUBSEQUENTLY, CUSTOMER¿S BLOOD GLUCOSE (BG) LEVEL DECREASED TO 40 MG/DL. REPORTEDLY, THE CUSTOMER CONSUMED CARBOHYDRATES TO ADDRESS BG LEVEL. RECOMMENDATION WAS MADE TO CONSULT WITH HEALTHCARE PROVIDER REGARDING DIABETES MANAGEMENT.
Patient problems: Hypoglycemia
MAUDE report 17190487 ↗InjurySep 9, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE CUSTOMER WENT TO THE EMERGENCY ROOM DUE TO LOW BLOOD GLUCOSE (BG) LEVEL OF 31MG/DL. THE CUSTOMER CONSUMED CARBOHYDRATES AND WAS TREATED WITH INTRAVENOUS SALINE TO ADDRESS BG LEVEL. THE CUSTOMER WAS DISCHARGED ON (B)(6) 2022 WITH NO PERMANENT INJURY. TANDEM TECHNICAL SUPPORT (CTS) REVIEWED PUMP DATA LOGS AND DETERMINED THAT THE CUSTOMER REQUESTED AND DELIVERED A 15 UNIT BOLUS VIA THE TANDEM MOBILE APPLICATION. REPORTEDLY, THE CUSTOMER HAD INTENDED TO DELIVER A 1.5 UNIT BOLUS. CTS EDUCATED THE CUSTOMER ON PROPER BOLUS DELIVERY PROCEDURE.
Patient problems: Hypoglycemia
MAUDE report 15396771 ↗
Other Continuous Glucose Monitor Secondary Display devices
- t:connect Mobile Application (iOS) 1004128Tandem Diabetes Care, Inc. · Continuous Glucose Monitor Secondary Display1 recall0 reports
- Dexcom Follow App for iOS SW10497Dexcom, Inc. · Continuous Glucose Monitor Secondary Display35 reports
- Dexcom Follow 5 Android Mobile SW14256Dexcom, Inc. · Continuous Glucose Monitor Secondary Display7 reports
- Dexcom Follow App for Android SW10583Dexcom, Inc. · Continuous Glucose Monitor Secondary Display6 reports
- LibreLinkUp 72154-01Abbott Diabetes Care Inc · Continuous glucose monitor secondary display4 reports
- Dexcom Follow 5 iOS Mobile SW14255Dexcom, Inc. · Continuous Glucose Monitor Secondary Display2 reports
- t:connect Mobile Application (Android) 1004127Tandem Diabetes Care, Inc. · Continuous Glucose Monitor Secondary Display1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.